paclitaxel has been researched along with Aortic Dissection in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, Y; Baba, S; Endo, F; Fujisawa, R; Koeda, K; Nikai, H; Sasaki, A | 1 |
| Funatsu, A; Kobayashi, T; Mizobuchi, M; Nakamura, S | 1 |
| Beschorner, U; Brechtel, K; Claussen, CD; Scheller, B; Schnorr, B; Speck, U; Tepe, G; Zeller, T | 1 |
| Cannavale, A; D'Adamo, A; Fanelli, F; Gazzetti, M | 1 |
| Yew, KL | 1 |
| Al-Ali, F; Barrow, T; Gupta, R; Hammer, MD; Horowitz, MB; Jovin, TG; Thomas, AJ; Uchino, K; Vora, NA; Wechsler, LR | 1 |
| Jiménez-Valero, S; Moreno, R; Sanchez-Recalde, A | 1 |
1 trial(s) available for paclitaxel and Aortic Dissection
| Article | Year |
|---|---|
High-grade, non-flow-limiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER study.
Topics: Aged; Angioplasty, Balloon; Aortic Dissection; Cardiovascular Agents; Coated Materials, Biocompatible; Constriction, Pathologic; Double-Blind Method; Equipment Design; Female; Femoral Artery; Germany; Humans; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Prospective Studies; Radiography; Recurrence; Regional Blood Flow; Retreatment; Risk Factors; Stents; Time Factors; Treatment Outcome; Vascular Access Devices | 2013 |
6 other study(ies) available for paclitaxel and Aortic Dissection
| Article | Year |
|---|---|
[A Thoracic Aortic Dissection Case during Treatment with Ramucirumab plus Nab-Paclitaxel].
Topics: Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aortic Dissection; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Ramucirumab; Stomach Neoplasms | 2020 |
Clinical and angiographic outcomes of coronary dissection after paclitaxel-coated balloon angioplasty for small vessel coronary artery disease.
Topics: Aged; Angioplasty, Balloon, Coronary; Aortic Dissection; Coated Materials, Biocompatible; Coronary Aneurysm; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Male; Paclitaxel; Retrospective Studies | 2019 |
Commentary: how do we deal with dissection after angioplasty?
Topics: Angioplasty, Balloon; Aortic Dissection; Cardiovascular Agents; Coated Materials, Biocompatible; Female; Femoral Artery; Humans; Male; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Vascular Access Devices | 2013 |
Successful treatment of fractional flow reserve wire induced coronary dissection and other coronary de novo lesion with paclitaxel coated balloon only.
Topics: Aortic Dissection; Cardiac Catheterization; Drug-Eluting Stents; Female; Fractional Flow Reserve, Myocardial; Humans; Middle Aged; Paclitaxel; Radiography; Treatment Outcome | 2014 |
Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation.
Topics: Anticoagulants; Aortic Dissection; Calcinosis; Carotid Artery, External; Carotid Artery, Internal; Carotid Stenosis; Catheterization; Cohort Studies; Drug Evaluation; Drug Implants; Feasibility Studies; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Organ Specificity; Paclitaxel; Recurrence; Retrospective Studies; Sirolimus; Stents; Stroke; Vertebrobasilar Insufficiency | 2006 |
Stenting of spontaneous intramural coronary haematoma: long-term consequences.
Topics: Aortic Dissection; Coronary Aneurysm; Drug-Eluting Stents; Female; Hematoma; Humans; Middle Aged; Paclitaxel; Tubulin Modulators; Ultrasonography, Interventional | 2008 |